Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00196079 · ClinicalTrials.gov registry record · NA
The ASPECT Study - Asian Paclitaxel-Eluting Stent Clinical Trial
A NA study, sponsored by Cook Group Incorporated.
- Completed
- Registry status
- NA
- Development phase
- 177
- Enrollment target
NCT00196079 is a NA study that has completed, run by Cook Group Incorporated. The registered enrollment target is 177 participants.
The verdict
NCT00196079, a NA study, has completed, sponsored by Cook Group Incorporated.
- COMPLETED
- Registry status
- NA
- Development phase
- 177 participants
- Enrollment target
Study Summary
The ASPECT study is an Asian multicenter, randomized, controlled, triple-blinded study designed to evaluate the ability of the Cook Incorporated Paclitaxel Eluting Supra G Coronary Stent to reduce restenosis in the coronary artery.
Interventions
- DEVICE Coronary stent
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 177 participants |
| Start Date | 2000-02 |
| Est. Completion | 2001-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00196079
The ClinicalTrials.gov registry entry for NCT00196079 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 177 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cook Group Incorporated, which has 31 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Coronary stent is the first listed.
NCT00196079 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00196079 about?
NCT00196079 is a clinical study titled "The ASPECT Study - Asian Paclitaxel-Eluting Stent Clinical Trial". The ASPECT study is an Asian multicenter, randomized, controlled, triple-blinded study designed to evaluate the ability of the Cook Incorporated Paclitaxel Eluting Supra G Coronary Stent to reduce restenosis in the coronary artery.
What is the current status of trial NCT00196079?
This trial is currently completed. It is a NA study. The enrollment target is 177 participants. The study started on 2000-02. Estimated completion is 2001-08.
What interventions are being tested in trial NCT00196079?
The interventions under investigation include: Coronary stent (DEVICE).
Who is sponsoring clinical trial NCT00196079?
This trial is sponsored by Cook Group Incorporated, which has 31 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.